Advertisement

Index by author

May 01, 1991; Volume 257,Issue 2

A

  1. Abe, Y

    1. MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.
      Y Kitada, Y Abe, A Narimatsu and A Tobe
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 812-819;

  2. Ahmad, S

    1. Interaction of trimebutine and Jo-1196 (fedotozine) with opioid receptors in the canine ileum.
      H D Allescher, S Ahmad, M Classen and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 836-842;

  3. Allescher, H D

    1. Interaction of trimebutine and Jo-1196 (fedotozine) with opioid receptors in the canine ileum.
      H D Allescher, S Ahmad, M Classen and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 836-842;

  4. Anderson, W R

    1. Antibodies raised against trifluoroacetyl-protein adducts bind to N-trifluoroacetyl-phosphatidylethanolamine in hexagonal phase phospholipid micelles.
      J R Trudell, C M Ardies and W R Anderson
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 657-662;

  5. Ardies, C M

    1. Antibodies raised against trifluoroacetyl-protein adducts bind to N-trifluoroacetyl-phosphatidylethanolamine in hexagonal phase phospholipid micelles.
      J R Trudell, C M Ardies and W R Anderson
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 657-662;

  6. Areso, P

    1. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
      G A Ordway, C Gambarana, S M Tejani-Butt, P Areso, M Hauptmann and A Frazer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 681-690;

B

  1. Baamonde, A

    1. Systemic administration of (Tyr-D-Ser(O-tert-butyl)-Gly-Phe-Leu-Thr(O-tert-butyl), a highly selective delta opioid agonist, induces mu receptor-mediated analgesia in mice.
      A Baamonde, V Daugé, G Gacel and B P Roques
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 767-773;

  2. Baglioni, C

    1. Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
      C Tetta, G Camussi, F Bussolino, K Herrick-Davis and C Baglioni
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 616-620;

  3. Baron, D A

    1. Monochloramine, a neutrophil-derived oxidant, stimulates rat colonic secretion.
      H Tamai, J F Kachur, D A Baron, M B Grisham and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 887-894;

  4. Bedrick, A

    1. Bombesin differentially affects gastric emptying in suckling, weanling and adult rats.
      Q Jiang, O Koldovsky, A Bedrick, P Pollack and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 603-607;

  5. Belknap, J K

    1. Acute dependence on depressant drugs is determined by common genes in mice.
      J C Crabbe, C Merrill and J K Belknap
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 663-667;

  6. Berger, V

    1. Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide.
      A Berson, C Wolf, V Berger, D Fau, C Chachaty, B Fromenty and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 714-719;

  7. Berson, A

    1. Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide.
      A Berson, C Wolf, V Berger, D Fau, C Chachaty, B Fromenty and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 714-719;

  8. Bevan, J A

    1. Variation in the interaction of some phenylethylamine and imidazoline derivatives with alpha-1 adrenoceptors in rabbit arteries: further evidence for the variable receptor affinity hypothesis.
      M A Oriowo, R D Bevan and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 651-656;
    2. Selective variation of agonist and neurally mediated vasoconstriction with rabbit middle cerebral artery branch order.
      D A Van Riper and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 879-886;

  9. Bevan, R D

    1. Variation in the interaction of some phenylethylamine and imidazoline derivatives with alpha-1 adrenoceptors in rabbit arteries: further evidence for the variable receptor affinity hypothesis.
      M A Oriowo, R D Bevan and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 651-656;

  10. Black, L E

    1. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
      S X Xu, Y Hatada, L E Black, I Creese and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 608-615;

  11. Bologa, M

    1. Pregnancy-induced changes in drug metabolism in epileptic women.
      M Bologa, B Tang, J Klein, A Tesoro and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 735-740;

  12. Brase, D A

    1. An insulin-independent mechanism of intrathecal morphine-induced hypoglycemia in mice: mediation through a central alpha-2 adrenergic pathway.
      D A Brase, C R Ward, H L Tripathi and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 587-594;

  13. Brown, D R

    1. Muscarinic cholinergic regulation of electrogenic chloride secretion in porcine proximal jejunum.
      R Chandan, B H Megarry, S M O'Grady, V S Seybold and D R Brown
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 908-917;

  14. Browning, M D

    1. Effects of dopamine receptor agonists and antagonists on catecholamine release in bovine chromaffin cells.
      P Huettl, G A Gerhardt, M D Browning and J M Masserano
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 567-574;

  15. Buckley, S K

    1. Bronchial vs. cardiovascular activities of selective phosphodiesterase inhibitors in the anesthetized beta-blocked dog.
      R J Heaslip, S K Buckley, B D Sickels and D Grimes
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 741-747;

  16. Bussolino, F

    1. Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
      C Tetta, G Camussi, F Bussolino, K Herrick-Davis and C Baglioni
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 616-620;

C

  1. Cadnapaphornchai, P

    1. Roles of adenosine and theophylline on the recovery of adenine nucleotides in postischemic cultured renal tubular cells.
      P Cadnapaphornchai, D Kellner, A Golembieski and F D McDonald
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 774-780;

  2. Campbell, B G

    1. N-methyl-D-aspartate receptor-mediated contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation: modulation by phencyclidine and glycine receptors.
      B G Campbell, P Couceyro, J F Keana and E Weber
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 754-766;

  3. Camussi, G

    1. Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
      C Tetta, G Camussi, F Bussolino, K Herrick-Davis and C Baglioni
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 616-620;

  4. Carton, E G

    1. Effects of nitrous oxide on contractility, relaxation and the intracellular calcium transient of isolated mammalian ventricular myocardium.
      E G Carton, L A Wanek and P R Housmans
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 843-849;

  5. Chachaty, C

    1. Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide.
      A Berson, C Wolf, V Berger, D Fau, C Chachaty, B Fromenty and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 714-719;

  6. Chandan, R

    1. Muscarinic cholinergic regulation of electrogenic chloride secretion in porcine proximal jejunum.
      R Chandan, B H Megarry, S M O'Grady, V S Seybold and D R Brown
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 908-917;

  7. Cimini, C M

    1. Reduction of cardiac hypertrophy in renal hypertensive rabbits with pindolol.
      C M Cimini, M A Gonzalez and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 541-546;

  8. Classen, M

    1. Interaction of trimebutine and Jo-1196 (fedotozine) with opioid receptors in the canine ileum.
      H D Allescher, S Ahmad, M Classen and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 836-842;

  9. Couceyro, P

    1. N-methyl-D-aspartate receptor-mediated contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation: modulation by phencyclidine and glycine receptors.
      B G Campbell, P Couceyro, J F Keana and E Weber
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 754-766;

  10. Crabbe, J C

    1. Acute dependence on depressant drugs is determined by common genes in mice.
      J C Crabbe, C Merrill and J K Belknap
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 663-667;

  11. Creese, I

    1. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
      S X Xu, Y Hatada, L E Black, I Creese and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 608-615;

  12. Culp, S

    1. Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration.
      R Zaczek, S Culp, H Goldberg, D J Mccann and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 820-829;
    2. Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport.
      R Zaczek, S Culp and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 830-835;

D

  1. Daniel, E E

    1. Interaction of trimebutine and Jo-1196 (fedotozine) with opioid receptors in the canine ileum.
      H D Allescher, S Ahmad, M Classen and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 836-842;

  2. Daugé, V

    1. Systemic administration of (Tyr-D-Ser(O-tert-butyl)-Gly-Phe-Leu-Thr(O-tert-butyl), a highly selective delta opioid agonist, induces mu receptor-mediated analgesia in mice.
      A Baamonde, V Daugé, G Gacel and B P Roques
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 767-773;

  3. De Souza, E B

    1. Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration.
      R Zaczek, S Culp, H Goldberg, D J Mccann and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 820-829;
    2. Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport.
      R Zaczek, S Culp and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 830-835;

  4. Dewey, W L

    1. An insulin-independent mechanism of intrathecal morphine-induced hypoglycemia in mice: mediation through a central alpha-2 adrenergic pathway.
      D A Brase, C R Ward, H L Tripathi and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 587-594;

  5. Drewett, J G

    1. Neuromodulatory effect of the atrial natriuretic factor clearance receptor binding peptide, cANF(4-23)-NH2 in rabbit isolated vasa deferentia.
      B G Johnson, G J Trachte and J G Drewett
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 720-726;

F

  1. Fanburg, B L

    1. Beta adrenergic antagonists inhibit serotonin uptake by pulmonary vascular cells in culture.
      S L Lee and B L Fanburg
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 895-900;

  2. Fau, D

    1. Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide.
      A Berson, C Wolf, V Berger, D Fau, C Chachaty, B Fromenty and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 714-719;

  3. Fondacaro, J D

    1. Action of peptidoleukotrienes on ion transport in rabbit distal colon in vitro.
      M F Jett, P Marshall, J D Fondacaro and P L Smith
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 698-705;

  4. France, C P

    1. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination.
      C P France, J M Moerschbaecher and J H Woods
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 727-734;

  5. Frank, G B

    1. Decrease in the size of tetanic responses produced by nitrendipine or by extracellular calcium ion removal without blocking twitches or action potentials in skeletal muscle.
      M Oz and G B Frank
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 575-581;

  6. Frazer, A

    1. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
      G A Ordway, C Gambarana, S M Tejani-Butt, P Areso, M Hauptmann and A Frazer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 681-690;

  7. Friedhoff, A J

    1. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
      E Meller, T Puza, J C Miller, A J Friedhoff and J W Schweitzer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 668-675;

  8. Fromenty, B

    1. Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide.
      A Berson, C Wolf, V Berger, D Fau, C Chachaty, B Fromenty and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 714-719;

  9. Fuji, K

    1. Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats.
      T Nabeshima, S Ogawa, H Nishimura, K Fuji, T Kameyama and Y Sasaki
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 562-566;

G

  1. Gacel, G

    1. Systemic administration of (Tyr-D-Ser(O-tert-butyl)-Gly-Phe-Leu-Thr(O-tert-butyl), a highly selective delta opioid agonist, induces mu receptor-mediated analgesia in mice.
      A Baamonde, V Daugé, G Gacel and B P Roques
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 767-773;

  2. Gackenheimer, S L

    1. Quantitative autoradiography of the binding sites for [125I] iodoglyburide, a novel high-affinity ligand for ATP-sensitive potassium channels in rat brain.
      D R Gehlert, S L Gackenheimer, D E Mais and D W Robertson
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 901-907;

  3. Gaginella, T S

    1. Monochloramine, a neutrophil-derived oxidant, stimulates rat colonic secretion.
      H Tamai, J F Kachur, D A Baron, M B Grisham and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 887-894;

  4. Gambarana, C

    1. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
      G A Ordway, C Gambarana, S M Tejani-Butt, P Areso, M Hauptmann and A Frazer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 681-690;

  5. Gehlert, D R

    1. Quantitative autoradiography of the binding sites for [125I] iodoglyburide, a novel high-affinity ligand for ATP-sensitive potassium channels in rat brain.
      D R Gehlert, S L Gackenheimer, D E Mais and D W Robertson
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 901-907;

  6. Gerhardt, G A

    1. Effects of dopamine receptor agonists and antagonists on catecholamine release in bovine chromaffin cells.
      P Huettl, G A Gerhardt, M D Browning and J M Masserano
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 567-574;

  7. Gillis, R A

    1. Propranolol promotes cocaine-induced spasm of porcine coronary artery.
      R Vargas, R A Gillis and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 644-646;
    2. The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.
      A K Mandal, K J Kellar and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 861-869;

  8. Giovanni, A

    1. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
      A Giovanni, B A Sieber, R E Heikkila and P K Sonsalla
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 691-697;

  9. Goldberg, H

    1. Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration.
      R Zaczek, S Culp, H Goldberg, D J Mccann and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 820-829;

  10. Golembieski, A

    1. Roles of adenosine and theophylline on the recovery of adenine nucleotides in postischemic cultured renal tubular cells.
      P Cadnapaphornchai, D Kellner, A Golembieski and F D McDonald
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 774-780;

  11. Gonzalez, M A

    1. Reduction of cardiac hypertrophy in renal hypertensive rabbits with pindolol.
      C M Cimini, M A Gonzalez and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 541-546;

  12. Goto, K

    1. Mechanisms of altered sensitivity to endothelin-1 between aortic smooth muscles of spontaneously hypertensive and Wistar-Kyoto rats.
      Y Tomobe, T Ishikawa, M Yanagisawa, S Kimura, T Masaki and K Goto
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 555-561;

  13. Grimes, D

    1. Bronchial vs. cardiovascular activities of selective phosphodiesterase inhibitors in the anesthetized beta-blocked dog.
      R J Heaslip, S K Buckley, B D Sickels and D Grimes
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 741-747;

  14. Grisham, M B

    1. Monochloramine, a neutrophil-derived oxidant, stimulates rat colonic secretion.
      H Tamai, J F Kachur, D A Baron, M B Grisham and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 887-894;

H

  1. Handa, S

    1. Effect of structural modification of several groups on the D-ring of grayanotoxin on its depolarization potency in squid giant axon.
      K Tsuji, T Kawanishi, S Handa, H Kamano, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 788-794;

  2. Hatada, Y

    1. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
      S X Xu, Y Hatada, L E Black, I Creese and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 608-615;

  3. Hauptmann, M

    1. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
      G A Ordway, C Gambarana, S M Tejani-Butt, P Areso, M Hauptmann and A Frazer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 681-690;

  4. Heaslip, R J

    1. Bronchial vs. cardiovascular activities of selective phosphodiesterase inhibitors in the anesthetized beta-blocked dog.
      R J Heaslip, S K Buckley, B D Sickels and D Grimes
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 741-747;

  5. Heikkila, R E

    1. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
      A Giovanni, B A Sieber, R E Heikkila and P K Sonsalla
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 691-697;

  6. Herrick-Davis, K

    1. Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
      C Tetta, G Camussi, F Bussolino, K Herrick-Davis and C Baglioni
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 616-620;

  7. Housmans, P R

    1. Effects of nitrous oxide on contractility, relaxation and the intracellular calcium transient of isolated mammalian ventricular myocardium.
      E G Carton, L A Wanek and P R Housmans
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 843-849;

  8. Huettl, P

    1. Effects of dopamine receptor agonists and antagonists on catecholamine release in bovine chromaffin cells.
      P Huettl, G A Gerhardt, M D Browning and J M Masserano
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 567-574;

I

  1. Ishikawa, T

    1. Mechanisms of altered sensitivity to endothelin-1 between aortic smooth muscles of spontaneously hypertensive and Wistar-Kyoto rats.
      Y Tomobe, T Ishikawa, M Yanagisawa, S Kimura, T Masaki and K Goto
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 555-561;
    2. Clebopride enhances contractility of the guinea pig stomach by blocking peripheral D2 dopamine receptor and alpha-2 adrenoceptor.
      K Takeda, K Taniyama, T Kuno, I Sano, T Ishikawa, I Ohmura and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 806-811;

  2. Ito, T

    1. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.
      N Yoshida, T Ito, T Karasawa and Z Itoh
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 781-787;

  3. Itoh, Z

    1. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.
      N Yoshida, T Ito, T Karasawa and Z Itoh
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 781-787;

  4. Iwasa, J

    1. Effect of structural modification of several groups on the D-ring of grayanotoxin on its depolarization potency in squid giant axon.
      K Tsuji, T Kawanishi, S Handa, H Kamano, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 788-794;

J

  1. Jett, M F

    1. Action of peptidoleukotrienes on ion transport in rabbit distal colon in vitro.
      M F Jett, P Marshall, J D Fondacaro and P L Smith
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 698-705;

  2. Jiang, Q

    1. Bombesin differentially affects gastric emptying in suckling, weanling and adult rats.
      Q Jiang, O Koldovsky, A Bedrick, P Pollack and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 603-607;

  3. Johanson, C E

    1. Discriminative stimulus effects of diazepam in humans.
      C E Johanson
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 634-643;

  4. Johnson, B G

    1. Neuromodulatory effect of the atrial natriuretic factor clearance receptor binding peptide, cANF(4-23)-NH2 in rabbit isolated vasa deferentia.
      B G Johnson, G J Trachte and J G Drewett
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 720-726;

  5. Joseph, M

    1. Interaction of SR 33557 with skeletal muscle calcium channel blocker receptors in the baboon: characterization of its binding sites.
      J Sol-Rolland, M Joseph and M Rinaldi-Carmona
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 595-602;

K

  1. Kachur, J F

    1. Monochloramine, a neutrophil-derived oxidant, stimulates rat colonic secretion.
      H Tamai, J F Kachur, D A Baron, M B Grisham and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 887-894;

  2. Kamano, H

    1. Effect of structural modification of several groups on the D-ring of grayanotoxin on its depolarization potency in squid giant axon.
      K Tsuji, T Kawanishi, S Handa, H Kamano, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 788-794;

  3. Kameyama, T

    1. Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats.
      T Nabeshima, S Ogawa, H Nishimura, K Fuji, T Kameyama and Y Sasaki
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 562-566;

  4. Kaneko, T

    1. A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.
      T Nakazawa, Y Yamanishi and T Kaneko
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 748-753;

  5. Kapitsopoulos, G

    1. Tolerance to morphine-like stimulus effects of mu opioid agonists.
      A M Young, G Kapitsopoulos and M M Makhay
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 795-805;

  6. Karasawa, T

    1. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.
      N Yoshida, T Ito, T Karasawa and Z Itoh
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 781-787;

  7. Katz, J L

    1. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
      J M Witkin, D E Nichols, P Terry and J L Katz
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 706-713;

  8. Kawanishi, T

    1. Effect of structural modification of several groups on the D-ring of grayanotoxin on its depolarization potency in squid giant axon.
      K Tsuji, T Kawanishi, S Handa, H Kamano, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 788-794;

  9. Keana, J F

    1. N-methyl-D-aspartate receptor-mediated contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation: modulation by phencyclidine and glycine receptors.
      B G Campbell, P Couceyro, J F Keana and E Weber
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 754-766;

  10. Kellar, K J

    1. The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.
      A K Mandal, K J Kellar and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 861-869;

  11. Kellner, D

    1. Roles of adenosine and theophylline on the recovery of adenine nucleotides in postischemic cultured renal tubular cells.
      P Cadnapaphornchai, D Kellner, A Golembieski and F D McDonald
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 774-780;

  12. Kimura, S

    1. Mechanisms of altered sensitivity to endothelin-1 between aortic smooth muscles of spontaneously hypertensive and Wistar-Kyoto rats.
      Y Tomobe, T Ishikawa, M Yanagisawa, S Kimura, T Masaki and K Goto
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 555-561;

  13. Kitada, Y

    1. MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.
      Y Kitada, Y Abe, A Narimatsu and A Tobe
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 812-819;

  14. Klein, J

    1. Pregnancy-induced changes in drug metabolism in epileptic women.
      M Bologa, B Tang, J Klein, A Tesoro and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 735-740;

  15. Koldovsky, O

    1. Bombesin differentially affects gastric emptying in suckling, weanling and adult rats.
      Q Jiang, O Koldovsky, A Bedrick, P Pollack and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 603-607;

  16. Koren, G

    1. Pregnancy-induced changes in drug metabolism in epileptic women.
      M Bologa, B Tang, J Klein, A Tesoro and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 735-740;

  17. Kuno, T

    1. Clebopride enhances contractility of the guinea pig stomach by blocking peripheral D2 dopamine receptor and alpha-2 adrenoceptor.
      K Takeda, K Taniyama, T Kuno, I Sano, T Ishikawa, I Ohmura and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 806-811;

L

  1. Lee, C S

    1. Changes of endogenous morphine and codeine contents in the fasting rat.
      C S Lee and S Spector
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 647-650;

  2. Lee, S L

    1. Beta adrenergic antagonists inhibit serotonin uptake by pulmonary vascular cells in culture.
      S L Lee and B L Fanburg
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 895-900;

  3. Lucki, I

    1. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.
      J L Neisewander, I Lucki and P McGonigle
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 850-860;

M

  1. Mais, D E

    1. Quantitative autoradiography of the binding sites for [125I] iodoglyburide, a novel high-affinity ligand for ATP-sensitive potassium channels in rat brain.
      D R Gehlert, S L Gackenheimer, D E Mais and D W Robertson
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 901-907;

  2. Makhay, M M

    1. Tolerance to morphine-like stimulus effects of mu opioid agonists.
      A M Young, G Kapitsopoulos and M M Makhay
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 795-805;

  3. Mandal, A K

    1. The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.
      A K Mandal, K J Kellar and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 861-869;

  4. Marshall, P

    1. Action of peptidoleukotrienes on ion transport in rabbit distal colon in vitro.
      M F Jett, P Marshall, J D Fondacaro and P L Smith
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 698-705;

  5. Masaki, T

    1. Mechanisms of altered sensitivity to endothelin-1 between aortic smooth muscles of spontaneously hypertensive and Wistar-Kyoto rats.
      Y Tomobe, T Ishikawa, M Yanagisawa, S Kimura, T Masaki and K Goto
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 555-561;

  6. Masserano, J M

    1. Effects of dopamine receptor agonists and antagonists on catecholamine release in bovine chromaffin cells.
      P Huettl, G A Gerhardt, M D Browning and J M Masserano
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 567-574;

  7. McCann, D J

    1. Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes.
      D J McCann and T P Su
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 547-554;

  8. Mccann, D J

    1. Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration.
      R Zaczek, S Culp, H Goldberg, D J Mccann and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 820-829;

  9. McDonald, F D

    1. Roles of adenosine and theophylline on the recovery of adenine nucleotides in postischemic cultured renal tubular cells.
      P Cadnapaphornchai, D Kellner, A Golembieski and F D McDonald
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 774-780;

  10. McGonigle, P

    1. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.
      J L Neisewander, I Lucki and P McGonigle
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 850-860;

  11. McWhorter, K

    1. Adrenergic interaction in mucin secretion of rat submandibular gland in vitro.
      S E Taylor and K McWhorter
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 582-586;

  12. Megarry, B H

    1. Muscarinic cholinergic regulation of electrogenic chloride secretion in porcine proximal jejunum.
      R Chandan, B H Megarry, S M O'Grady, V S Seybold and D R Brown
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 908-917;

  13. Meller, E

    1. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
      E Meller, T Puza, J C Miller, A J Friedhoff and J W Schweitzer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 668-675;

  14. Merrill, C

    1. Acute dependence on depressant drugs is determined by common genes in mice.
      J C Crabbe, C Merrill and J K Belknap
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 663-667;

  15. Miller, J C

    1. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
      E Meller, T Puza, J C Miller, A J Friedhoff and J W Schweitzer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 668-675;

  16. Moerschbaecher, J M

    1. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination.
      C P France, J M Moerschbaecher and J H Woods
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 727-734;

N

  1. Nabeshima, T

    1. Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats.
      T Nabeshima, S Ogawa, H Nishimura, K Fuji, T Kameyama and Y Sasaki
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 562-566;

  2. Nakazawa, T

    1. A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.
      T Nakazawa, Y Yamanishi and T Kaneko
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 748-753;

  3. Narimatsu, A

    1. MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.
      Y Kitada, Y Abe, A Narimatsu and A Tobe
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 812-819;

  4. Neisewander, J L

    1. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.
      J L Neisewander, I Lucki and P McGonigle
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 850-860;

  5. Nichols, D E

    1. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
      J M Witkin, D E Nichols, P Terry and J L Katz
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 706-713;

  6. Nicklas, W J

    1. Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition.
      G D Zeevalk and W J Nicklas
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 870-878;

  7. Nishimura, H

    1. Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats.
      T Nabeshima, S Ogawa, H Nishimura, K Fuji, T Kameyama and Y Sasaki
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 562-566;

O

  1. O'Grady, S M

    1. Muscarinic cholinergic regulation of electrogenic chloride secretion in porcine proximal jejunum.
      R Chandan, B H Megarry, S M O'Grady, V S Seybold and D R Brown
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 908-917;

  2. Ogawa, S

    1. Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats.
      T Nabeshima, S Ogawa, H Nishimura, K Fuji, T Kameyama and Y Sasaki
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 562-566;

  3. Ohmura, I

    1. Clebopride enhances contractility of the guinea pig stomach by blocking peripheral D2 dopamine receptor and alpha-2 adrenoceptor.
      K Takeda, K Taniyama, T Kuno, I Sano, T Ishikawa, I Ohmura and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 806-811;

  4. Ordway, G A

    1. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
      G A Ordway, C Gambarana, S M Tejani-Butt, P Areso, M Hauptmann and A Frazer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 681-690;

  5. Oriowo, M A

    1. Variation in the interaction of some phenylethylamine and imidazoline derivatives with alpha-1 adrenoceptors in rabbit arteries: further evidence for the variable receptor affinity hypothesis.
      M A Oriowo, R D Bevan and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 651-656;

  6. Oz, M

    1. Decrease in the size of tetanic responses produced by nitrendipine or by extracellular calcium ion removal without blocking twitches or action potentials in skeletal muscle.
      M Oz and G B Frank
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 575-581;

P

  1. Pessayre, D

    1. Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide.
      A Berson, C Wolf, V Berger, D Fau, C Chachaty, B Fromenty and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 714-719;

  2. Pollack, P

    1. Bombesin differentially affects gastric emptying in suckling, weanling and adult rats.
      Q Jiang, O Koldovsky, A Bedrick, P Pollack and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 603-607;

  3. Porreca, F

    1. Bombesin differentially affects gastric emptying in suckling, weanling and adult rats.
      Q Jiang, O Koldovsky, A Bedrick, P Pollack and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 603-607;

  4. Portoghese, P S

    1. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
      M Sofuoglu, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 676-680;

  5. Puza, T

    1. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
      E Meller, T Puza, J C Miller, A J Friedhoff and J W Schweitzer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 668-675;

R

  1. Ramwell, P W

    1. Propranolol promotes cocaine-induced spasm of porcine coronary artery.
      R Vargas, R A Gillis and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 644-646;

  2. Rinaldi-Carmona, M

    1. Interaction of SR 33557 with skeletal muscle calcium channel blocker receptors in the baboon: characterization of its binding sites.
      J Sol-Rolland, M Joseph and M Rinaldi-Carmona
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 595-602;

  3. Robertson, D W

    1. Quantitative autoradiography of the binding sites for [125I] iodoglyburide, a novel high-affinity ligand for ATP-sensitive potassium channels in rat brain.
      D R Gehlert, S L Gackenheimer, D E Mais and D W Robertson
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 901-907;

  4. Roques, B P

    1. Systemic administration of (Tyr-D-Ser(O-tert-butyl)-Gly-Phe-Leu-Thr(O-tert-butyl), a highly selective delta opioid agonist, induces mu receptor-mediated analgesia in mice.
      A Baamonde, V Daugé, G Gacel and B P Roques
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 767-773;

  5. Rosenbaum, J S

    1. Bradykinin-stimulated inositol phosphate production in NG108-15 cells is mediated by a small population of binding sites which rapidly desensitize.
      D H Wolsing and J S Rosenbaum
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 621-633;

S

  1. Sano, I

    1. Clebopride enhances contractility of the guinea pig stomach by blocking peripheral D2 dopamine receptor and alpha-2 adrenoceptor.
      K Takeda, K Taniyama, T Kuno, I Sano, T Ishikawa, I Ohmura and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 806-811;

  2. Sasaki, Y

    1. Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats.
      T Nabeshima, S Ogawa, H Nishimura, K Fuji, T Kameyama and Y Sasaki
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 562-566;

  3. Schweitzer, J W

    1. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
      E Meller, T Puza, J C Miller, A J Friedhoff and J W Schweitzer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 668-675;

  4. Seyama, I

    1. Effect of structural modification of several groups on the D-ring of grayanotoxin on its depolarization potency in squid giant axon.
      K Tsuji, T Kawanishi, S Handa, H Kamano, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 788-794;

  5. Seybold, V S

    1. Muscarinic cholinergic regulation of electrogenic chloride secretion in porcine proximal jejunum.
      R Chandan, B H Megarry, S M O'Grady, V S Seybold and D R Brown
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 908-917;

  6. Sibley, D R

    1. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
      S X Xu, Y Hatada, L E Black, I Creese and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 608-615;

  7. Sickels, B D

    1. Bronchial vs. cardiovascular activities of selective phosphodiesterase inhibitors in the anesthetized beta-blocked dog.
      R J Heaslip, S K Buckley, B D Sickels and D Grimes
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 741-747;

  8. Sieber, B A

    1. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
      A Giovanni, B A Sieber, R E Heikkila and P K Sonsalla
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 691-697;

  9. Smith, P L

    1. Action of peptidoleukotrienes on ion transport in rabbit distal colon in vitro.
      M F Jett, P Marshall, J D Fondacaro and P L Smith
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 698-705;

  10. Sofuoglu, M

    1. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
      M Sofuoglu, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 676-680;

  11. Sol-Rolland, J

    1. Interaction of SR 33557 with skeletal muscle calcium channel blocker receptors in the baboon: characterization of its binding sites.
      J Sol-Rolland, M Joseph and M Rinaldi-Carmona
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 595-602;

  12. Sonsalla, P K

    1. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
      A Giovanni, B A Sieber, R E Heikkila and P K Sonsalla
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 691-697;

  13. Spector, S

    1. Changes of endogenous morphine and codeine contents in the fasting rat.
      C S Lee and S Spector
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 647-650;

  14. Su, T P

    1. Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes.
      D J McCann and T P Su
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 547-554;

T

  1. Takeda, K

    1. Clebopride enhances contractility of the guinea pig stomach by blocking peripheral D2 dopamine receptor and alpha-2 adrenoceptor.
      K Takeda, K Taniyama, T Kuno, I Sano, T Ishikawa, I Ohmura and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 806-811;

  2. Takemori, A E

    1. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
      M Sofuoglu, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 676-680;

  3. Tamai, H

    1. Monochloramine, a neutrophil-derived oxidant, stimulates rat colonic secretion.
      H Tamai, J F Kachur, D A Baron, M B Grisham and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 887-894;

  4. Tanaka, C

    1. Clebopride enhances contractility of the guinea pig stomach by blocking peripheral D2 dopamine receptor and alpha-2 adrenoceptor.
      K Takeda, K Taniyama, T Kuno, I Sano, T Ishikawa, I Ohmura and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 806-811;

  5. Tang, B

    1. Pregnancy-induced changes in drug metabolism in epileptic women.
      M Bologa, B Tang, J Klein, A Tesoro and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 735-740;

  6. Taniyama, K

    1. Clebopride enhances contractility of the guinea pig stomach by blocking peripheral D2 dopamine receptor and alpha-2 adrenoceptor.
      K Takeda, K Taniyama, T Kuno, I Sano, T Ishikawa, I Ohmura and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 806-811;

  7. Taylor, S E

    1. Adrenergic interaction in mucin secretion of rat submandibular gland in vitro.
      S E Taylor and K McWhorter
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 582-586;

  8. Tejani-Butt, S M

    1. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
      G A Ordway, C Gambarana, S M Tejani-Butt, P Areso, M Hauptmann and A Frazer
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 681-690;

  9. Terry, P

    1. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
      J M Witkin, D E Nichols, P Terry and J L Katz
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 706-713;

  10. Tesoro, A

    1. Pregnancy-induced changes in drug metabolism in epileptic women.
      M Bologa, B Tang, J Klein, A Tesoro and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 735-740;

  11. Tetta, C

    1. Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
      C Tetta, G Camussi, F Bussolino, K Herrick-Davis and C Baglioni
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 616-620;

  12. Tobe, A

    1. MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.
      Y Kitada, Y Abe, A Narimatsu and A Tobe
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 812-819;

  13. Tomobe, Y

    1. Mechanisms of altered sensitivity to endothelin-1 between aortic smooth muscles of spontaneously hypertensive and Wistar-Kyoto rats.
      Y Tomobe, T Ishikawa, M Yanagisawa, S Kimura, T Masaki and K Goto
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 555-561;

  14. Trachte, G J

    1. Neuromodulatory effect of the atrial natriuretic factor clearance receptor binding peptide, cANF(4-23)-NH2 in rabbit isolated vasa deferentia.
      B G Johnson, G J Trachte and J G Drewett
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 720-726;

  15. Tripathi, H L

    1. An insulin-independent mechanism of intrathecal morphine-induced hypoglycemia in mice: mediation through a central alpha-2 adrenergic pathway.
      D A Brase, C R Ward, H L Tripathi and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 587-594;

  16. Trudell, J R

    1. Antibodies raised against trifluoroacetyl-protein adducts bind to N-trifluoroacetyl-phosphatidylethanolamine in hexagonal phase phospholipid micelles.
      J R Trudell, C M Ardies and W R Anderson
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 657-662;

  17. Tsuji, K

    1. Effect of structural modification of several groups on the D-ring of grayanotoxin on its depolarization potency in squid giant axon.
      K Tsuji, T Kawanishi, S Handa, H Kamano, J Iwasa and I Seyama
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 788-794;

V

  1. Van Riper, D A

    1. Selective variation of agonist and neurally mediated vasoconstriction with rabbit middle cerebral artery branch order.
      D A Van Riper and J A Bevan
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 879-886;

  2. Vargas, R

    1. Propranolol promotes cocaine-induced spasm of porcine coronary artery.
      R Vargas, R A Gillis and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 644-646;

W

  1. Wanek, L A

    1. Effects of nitrous oxide on contractility, relaxation and the intracellular calcium transient of isolated mammalian ventricular myocardium.
      E G Carton, L A Wanek and P R Housmans
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 843-849;

  2. Ward, C R

    1. An insulin-independent mechanism of intrathecal morphine-induced hypoglycemia in mice: mediation through a central alpha-2 adrenergic pathway.
      D A Brase, C R Ward, H L Tripathi and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 587-594;

  3. Weber, E

    1. N-methyl-D-aspartate receptor-mediated contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation: modulation by phencyclidine and glycine receptors.
      B G Campbell, P Couceyro, J F Keana and E Weber
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 754-766;

  4. Weiss, H R

    1. Reduction of cardiac hypertrophy in renal hypertensive rabbits with pindolol.
      C M Cimini, M A Gonzalez and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 541-546;

  5. Witkin, J M

    1. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
      J M Witkin, D E Nichols, P Terry and J L Katz
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 706-713;

  6. Wolf, C

    1. Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide.
      A Berson, C Wolf, V Berger, D Fau, C Chachaty, B Fromenty and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 714-719;

  7. Wolsing, D H

    1. Bradykinin-stimulated inositol phosphate production in NG108-15 cells is mediated by a small population of binding sites which rapidly desensitize.
      D H Wolsing and J S Rosenbaum
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 621-633;

  8. Woods, J H

    1. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination.
      C P France, J M Moerschbaecher and J H Woods
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 727-734;

X

  1. Xu, S X

    1. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
      S X Xu, Y Hatada, L E Black, I Creese and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 608-615;

Y

  1. Yamanishi, Y

    1. A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.
      T Nakazawa, Y Yamanishi and T Kaneko
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 748-753;

  2. Yanagisawa, M

    1. Mechanisms of altered sensitivity to endothelin-1 between aortic smooth muscles of spontaneously hypertensive and Wistar-Kyoto rats.
      Y Tomobe, T Ishikawa, M Yanagisawa, S Kimura, T Masaki and K Goto
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 555-561;

  3. Yoshida, N

    1. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.
      N Yoshida, T Ito, T Karasawa and Z Itoh
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 781-787;

  4. Young, A M

    1. Tolerance to morphine-like stimulus effects of mu opioid agonists.
      A M Young, G Kapitsopoulos and M M Makhay
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 795-805;

Z

  1. Zaczek, R

    1. Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration.
      R Zaczek, S Culp, H Goldberg, D J Mccann and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 820-829;
    2. Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport.
      R Zaczek, S Culp and E B De Souza
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 830-835;

  2. Zeevalk, G D

    1. Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition.
      G D Zeevalk and W J Nicklas
      Journal of Pharmacology and Experimental Therapeutics May 1991, 257 (2) 870-878;
Back to top

In this issue

Advertisement